Cognito Therapeutics today announced new data from its OVERTURE feasibility trial evaluating its Spectris neuromodulation ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes ...

Josiah Blanton is the youngest franchisee in Harold's history and will open his new location later this spring. The 2,200 ...

A research group led by Takumi Kagawa and Masashi Kato at Nagoya University Graduate School of Medicine has discovered that ...

Researchers at the Institute of Automation of the Chinese Academy of Sciences have developed a compact, battery-powered brain ...

Despite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of ...